Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials

Cannabidiol (CBD) is one of the cannabinoids with non-psychotropic action, extracted from Cannabis sativa. CBD is a terpenophenol and it has received a great scientific interest thanks to its medical applications. This compound showed efficacy as anti-seizure, antipsychotic, neuroprotective, antidepressant and anxiolytic. The results of scientific studies obtained so far the use of CBD in clinical applications could represent hope for patients who are resistant to all conventional anti-epileptic drugs.

The post Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials appeared first on Weed World Magazine.